20 July 2009

Rubinstein-Taybi Syndrome

A malformation syndrome characterised by facial abnormalities, broad thumbs, broad great toes, short stature, and mental retardation.1 It was first described in 1963 by Rubinstein and Taybi.2

Epidemiology
  • Incidence is about 1 case per 100,000 live births.3
  • Most cases of are sporadic, although the syndrome has been reported in monozygotic twins.4
Presentation


  • Facial abnormalities: hypoplastic maxilla with narrow palate, prominent beaked nose, antimongoloid eye slant, low-set/malformed ears, strabismus.

  • Digital abnormalities: broad thumbs, fingers and great toes.
  • Abnormalities of growth and development: severe mental retardation, sleep apnoea, speech difficulties, hypotonia, growth retardation.
  • Skeletal abnormalities: patellar dislocation.
  • Skin: hirsutism, capillary nevus of the forehead.
  • Cardiovascular abnormalities, including ventricular septal defects, patent ductus arteriosus.5
  • Ocular abnormalities occur in the majority of patients. The abnormalities are diverse but include retinal dysfunction, which has been reported to occur in 78% of patients.6
  • Cryptorchidism in males.
  • Mood disorders and obsessive-compulsive disorder.
  • Recurrent respiratory tract infections.7
Differential diagnosis

Other similar syndromes to consider in the diagnosis are faciodigitogenital syndrome, Greig syndrome, Larsen syndrome, Pfeiffer syndrome, Saethre-Chotzen syndrome, Simpson-Golabi-Behmel syndrome and Weaver syndrome.

Investigations
  • The investigations will depend on the clinical manifestations of the patient.
  • Skeletal deformities may require CT and MRI scans as well as x-rays.
  • Cardiac assessment, including echocardiography, for congenital heart disease.
  • Eye and vision assessment for ocular abnormalities.
  • Ear, nose and throat, and hearing assessment.
Management
  • The wide spectrum of clinical manifestations requires disease management tailored to the problems of each patient.
  • Physiotherapy, speech therapy and special education are all required.
  • Families of affected children need a great deal of support and all management intervention must be carefully coordinated and periodically reviewed.
Prognosis
  • The survival rate is good, with frequent reports of survival to adulthood.
  • Affected children suffer from developmental delay, growth retardation and feeding difficulties.
  • Respiratory tract infections and complications from congenital heart disease are primary causes of morbidity and mortality in infancy.1

Document references
  1. Mijuskovic ZP; Rubinstein-Taybi Syndrome. eMedicine, September 2006.
  2. Rubinstein JH, Taybi H; Broad thumbs and toes and facial abnormalities. Am J Dis Child 1963; 105: 588-608.
  3. Roelfsema JH, Peters DJ; Rubinstein-Taybi syndrome: clinical and molecular overview. Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. [abstract]
  4. Baraitser M, Preece MA; The Rubinstein-Taybi syndrome: occurrence in two sets of identical twins. Clin Genet. 1983 Apr;23(4):318-20.
  5. Stevens CA, Bhakta MG; Cardiac abnormalities in the Rubinstein-Taybi syndrome. Am J Med Genet. 1995 Nov 20;59(3):346-8. [abstract]
  6. van Genderen MM, Kinds GF, Riemslag FC, et al; Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br J Ophthalmol. 2000 Oct;84(10):1177-84. [abstract]
  7. Naimi DR, Munoz J, Rubinstein J, et al; Rubinstein-Taybi syndrome: an immune deficiency as a cause for recurrent infections. Allergy Asthma Proc. 2006 May-Jun;27(3):281-4. [abstract]

Internet and further reading
Acknowledgements EMIS is grateful to Dr Colin Tidy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2008.


Sumber: dari sini

No comments:

Post a Comment